Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: N/A
Brief Summary: Assessment of the effect of hyperoxia and hypertonic saline on survival in patients with septic shock Hyperoxia and hypertonic saline may have beneficial effects on organ perfusion and oxygenation and may reduce the organ failure occurences. To date, only scarce data are available. Side effects are not well described. Therefore we designed a randomized clinical trial in order to assess the early administration of hypertonic saline and oxygen in the very early beginning of septic shock.


Options:
A: Arm Label: Group 1; Type: ACTIVE_COMPARATOR; Interventions: Other: Low normal PaCO2, Other: Low normal PaO2, Other: Low normal MAP | Arm Label: Group 2; Type: ACTIVE_COMPARATOR; Interventions: Other: High normal PaCO2, Other: Low normal PaO2, Other: Low normal MAP | Arm Label: Group 3; Type: ACTIVE_COMPARATOR; Interventions: Other: Low normal PaCO2, Other: High normal PaO2, Other: Low normal MAP | Arm Label: Group 4; Type: ACTIVE_COMPARATOR; Interventions: Other: High normal PaCO2, Other: High normal PaO2, Other: Low normal MAP | Arm Label: Group 5; Type: ACTIVE_COMPARATOR; Interventions: Other: Low normal PaCO2, Other: Low normal PaO2, Other: High normal MAP | Arm Label: Group 6; Type: ACTIVE_COMPARATOR; Interventions: Other: High normal PaCO2, Other: Low normal PaO2, Other: High normal MAP | Arm Label: Group 7; Type: ACTIVE_COMPARATOR; Interventions: Other: Low normal PaCO2, Other: High normal PaO2, Other: High normal MAP | Arm Label: Group 8; Type: ACTIVE_COMPARATOR; Interventions: Other: High normal PaCO2, Other: High normal PaO2, Other: High normal MAP | Intervention Type: OTHER; Name: Low normal PaCO2; Assigned to Arm(s): Group 1, Group 3, Group 5, Group 7 | Intervention Type: OTHER; Name: High normal PaCO2; Assigned to Arm(s): Group 2, Group 4, Group 6, Group 8 | Intervention Type: OTHER; Name: Low normal PaO2; Assigned to Arm(s): Group 1, Group 2, Group 5, Group 6 | Intervention Type: OTHER; Name: High normal PaO2; Assigned to Arm(s): Group 3, Group 4, Group 7, Group 8 | Intervention Type: OTHER; Name: Low normal MAP; Assigned to Arm(s): Group 1, Group 2, Group 3, Group 4 | Intervention Type: OTHER; Name: High normal MAP; Assigned to Arm(s): Group 5, Group 6, Group 7, Group 8
B: Arm Label: Oxygenation, rigorous normal; Type: EXPERIMENTAL; Interventions: Drug: Oxygen | Arm Label: Oxygen, free conventional; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DRUG; Name: Oxygen; Assigned to Arm(s): Oxygenation, rigorous normal
C: Arm Label: A; Type: ACTIVE_COMPARATOR; Interventions: Drug: Oxygen | Arm Label: B; Type: ACTIVE_COMPARATOR; Interventions: Drug: Oxygen | Intervention Type: DRUG; Name: Oxygen; Assigned to Arm(s): A, B
D: Arm Label: normoxia and isotonic saline; Type: PLACEBO_COMPARATOR; Interventions: Drug: oxygen and saline | Arm Label: normoxia and 3% hypertonic saline; Type: ACTIVE_COMPARATOR; Interventions: Drug: oxygen and saline | Arm Label: hyperoxia and isotonic saline; Type: ACTIVE_COMPARATOR; Interventions: Drug: oxygen and saline | Arm Label: hyperoxia and 3% hypertonic saline; Type: ACTIVE_COMPARATOR; Interventions: Drug: oxygen and saline | Intervention Type: DRUG; Name: oxygen and saline; Assigned to Arm(s): hyperoxia and 3% hypertonic saline, hyperoxia and isotonic saline, normoxia and 3% hypertonic saline, normoxia and isotonic saline

Answer: D